Literature DB >> 29970531

Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers.

Katsuo Usuda1, Syun Iwai2, Aika Funasaki2, Atsushi Sekimura2, Nozomu Motono2, Yoshimiti Ueda3, Miyako Shimazaki3, Hidetaka Uramoto2.   

Abstract

BACKGROUND/AIM: One of the most important factors concerning cancer growth is angiogenesis. The purpose of this study was to clarify the relationship of maturation of tumor vessels and prognosis of lung cancer.
MATERIALS AND METHODS: Immunohistochemical stainings of 125 lung cancers for VEGF, CD31 and α-smooth muscle actin (αSMA) were scored by multiplying the intensity and the frequency from 0 to 12.
RESULTS: Adenocarcinomas showed significantly higher staining scores of both VEGF and αSMA than squamous cell carcinomas did. In 42 cases of high CD31 score, five-year survival rate (87%) of patients with lung cancer showing mature tumor vessels was significantly better than that (69%) of patients with immature tumor vessels.
CONCLUSION: Not the number of tumor vessels but their maturation may be a prognostic factor of patients with lung cancer. VEGF may not only stimulate proliferation of endothelial cells but also their maturation in differentiated lung cancers. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Lung cancer; VEGF; maturation; prognostic factor; tumor vessels

Mesh:

Substances:

Year:  2018        PMID: 29970531     DOI: 10.21873/anticanres.12695

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.

Authors:  Lei Zhang; Ying Chen; Fangxuan Li; Lewen Bao; Wenxin Liu
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

2.  Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer.

Authors:  Rafał Suwinski; Monika Giglok; Katarzyna Galwas-Kliber; Adam Idasiak; Bozena Jochymek; Regina Deja; Barbara Maslyk; Jolanta Mrochem-Kwarciak; Dorota Butkiewicz
Journal:  BMC Cancer       Date:  2019-05-08       Impact factor: 4.430

3.  The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients.

Authors:  Peter Ella-Tongwiis; Rebecca May Lamb; Alexander Makanga; Iqbal Shergill; Stephen Fôn Hughes
Journal:  BMC Urol       Date:  2020-11-25       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.